Cases 1 - 3 of 3
In Re: Ozempic (Semaglutide) Patent Litigation
as 1:2022md03038
Not Classified By Court:
Zydus Lifesciences Limited, Ozempic (Semaglutide) Patent Litigation, Novo Nordisk Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Alvogen, Inc.
as 1:2022cv00299
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Alvogen, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Noven Pharmaceuticals, Inc. v. Alvogen Pine Brook LLC et al
as 1:2017cv01429
Plaintiff:
Noven Pharmaceuticals, Inc.
Defendant:
Alvogen Pine Brook LLC and Alvogen, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
